GlassScriptPhysician profile
Robert Byron Osborne
NPI 1962481556
$10,183.83
in general payments reported to CMS, 2019-2025
49 companies · $1,988 in 2025
The $1,988 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,361 · 2020: $583 · 2021: $1,376 · 2022: $1,756 · 2023: $1,490 · 2024: $1,630 · 2025: $1,988.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,895 · Education: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,894.74 |
| Education | $213.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,357.82 | 2019-2025 | Erleada, Akeega |
| Pfizer INC. | $1,293.24 | 2019-2025 | |
| Astellas Pharma US INC | $1,190.48 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Abbvie INC. | $795.41 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $715.51 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $524.56 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $499.07 | 2023-2025 | Gemtesa, Orgovyx |
| Accord Healthcare, INC. | $353.24 | 2023-2025 | |
| Urovant Sciences INC | $294.65 | 2021-2022 | |
| Myovant Sciences INC. | $270.11 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $235.44 | 2019-2024 | Xiaflex, Aveed |
| Teleflex LLC | $216.41 | 2021-2025 | Barrigel, Urolift |
| Progenics Pharmaceuticals, INC. | $176.38 | 2023-2025 | Pylarify |
| Endo USA, INC. | $165.90 | 2024-2025 | Xiaflex, Aveed |
| Axonics, INC. | $151.61 | 2020-2024 | Axonics |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Osborne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.